LincRNA 1700020I14Rik alleviates cell proliferation and fibrosis in diabetic nephropathy via miR-34a-5p/Sirt1/HIF-1α signaling
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Link
http://www.nature.com/articles/s41419-018-0527-8.pdf
Reference42 articles.
1. Yiu, W. H., Lin, M. & Tang, S. C. Toll-like receptor activation: from renal inflammation to fibrosis. Kidney Int Suppl. 4, 20–25 (2011).
2. Kume, S., Kitada, M., Kanasaki, K., Maegawa, H. & Koya, D. Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy. Arch. PharmRes. 36, 230–236 (2013).
3. Li, C. et al. Tetrahy droxystilbene glucoside ameliorates diabetic nephropathy in rats: involvement of SIRT1 and TGF-β1pathway. Eur. J. Pharmacol. 649, 382–389 (2010).
4. Kitada, M. & Koya, D. SIRT1 in type 2 diabetes: mechanisms and therapeutic potential. Diabetes Metab. J. 37, 315–325 (2013).
5. Chuang, P. Y. et al. Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus. PLoS One 6, e23566 (2011).
Cited by 125 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Sfrp2 promotes renal dysfunction of diabetic kidney disease via modulating Fzd5-induced cytosolic calcium ion concentration and CaMKII/Mek/Erk pathway in mesangial cells;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-02
2. Metformin inhibits high glucose‐induced apoptosis of renal podocyte through regulating miR‐34a/SIRT1 axis;Immunity, Inflammation and Disease;2024-01
3. miR-338-3p and miR-34a-5p act as antagonists in phycocyanin-mediated process of ameliorating glycometabolism in T2DM HepG2 cells;Journal of Functional Foods;2024-01
4. The function of miRNAs in the process of kidney development;Non-coding RNA Research;2023-12
5. Astragalus polysaccharide promotes autophagy and alleviates diabetic nephropathy by targeting the lncRNA Gm41268/PRLR pathway;Renal Failure;2023-11-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3